Oral chinese herbal medicine for improvement of quality of life in patients with stable chronic obstructive pulmonary disease: A systematic review

Journal of Alternative and Complementary Medicine

Volumn 18, Issue 8, 2012, Pages 731-743

  An, Xuedong ^a   Zhang, Anthony Lin ^a   May, Brian H ^a   Lin, Lin ^b   Xu, Yinji ^b   Xue, Charlie Changli ^a  

^a RMIT UNIVERSITY   (Australia)

^b GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BAIBUYANGFEI; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUFEI; BUFEITANG; BUSHENNAQI; CHOLINERGIC RECEPTOR BLOCKING AGENT; DONGPINGTANG; FLUTICASONE; HERBACEOUS AGENT; HUATANHUOXUE; IPRATROPIUM BROMIDE; PEITUSHENGJINTANG; PINGCHUAN; PLACEBO; PREDNISONE; QIWEIDUQITANG; RENSHENGEJIETANG; SALBUTAMOL; SALMETEROL; TERBUTALINE SULFATE; THEOPHYLLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; YIQIHUOXUE; YIQIHUOXUEHUATAN; YIQIHUOXUEHUATANTONGLUO; YUFEINING; YUPINGFENG; ZOUFEI; ZOUFEITANG;

ASTRAGALUS MEMBRANACEUS; BLOATING; CHINESE MEDICINE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CODONOPSIS PILOSULA; FRUIT; HERBAL MEDICINE; HUMAN; OUTCOME ASSESSMENT; PLANT ROOT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHIZOME; SYSTEMATIC ERROR; SYSTEMATIC REVIEW; XEROSTOMIA;

ACTIVITIES OF DAILY LIVING; DRUGS, CHINESE HERBAL; HUMANS; PHYTOTHERAPY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE;

EID: 84865238213     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2011.0389     Document Type: Review

References (51)

1. Mathers CD, Boerma T, Ma Fat D. Global and regional causes of death. Br Med Bull 2009;92:7-32.
2. McKenzie DK, Abramson M, Crockett AJ, et al. The COPD-X Plan: Australian and New Zealand Guidelines for the Management of Chronic Obstructive Pulmonary Disease. 2010. Online document at: http://www.copdx.org.au Accessed February 11, 2011.
3. GOLD. Global Strategy for Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (GOLD) (Executive Summary). 2009. Online document at: www.goldcopd.org Accessed February 7, 2010.
4. Fabbri LM, Calverley PM, Izquierdo-Alonso JL, et al. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodila-tors: Two randomised clinical trials. Lancet 2009;374: 695-703.
5. Dougherty JA, Didur BL, Aboussouan LS. Long-acting inhaled beta 2-agonists for stable COPD. Ann Pharmacother 2003;37:1247-1255. (Pubitemid 37040218)
6. Restrepo RD. Use of inhaled anticholinergic agents in obstructive airway disease. Respir Care 2007;52:833-851.
7. Tashkin DP, Hanania NA, McGinty J, et al. Nebulized for-moterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease. Adv Ther 2009;26: 1024-1034.
8. Guo R, Pittler MH, Ernst E. Herbal medicines for the treatment of COPD: A systematic review. Eur Respir J 2006;28: 330-338. (Pubitemid 44914232)
9. Mehta DH, Gardiner PM, Phillips RS, McCarthy EP. Herbal and dietary supplement disclosure to health care providers by individuals with chronic conditions. J Altern Complement Med 2008;14:1263-1269.
10. An X, Zhang AL, Yang AW, et al. Oral ginseng formulae for stable chronic obstructive pulmonary disease: A systematic review. Respir Med 2011;105:165-176.
11. Beretta L, Santaniello A, Lemos A, et al. Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis. Rheumatology (Oxf) 2007;46:296-301. (Pubitemid 46189792)
12. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions (Version 5.0.1). 2008. Online document at: www.cochrane-handbook. org Accessed August 18, 2009.
13. CSRD. Chronic obstructive pulmonary disease diagnosis and treatment guidelines (revised version): Chinese Society of Respiratory Diseases (CSRD) (chronic obstructive pulmonary disease study group). Chin J Tuberculosis Resp Chin J Tuberc Respir Dis 2002;25:453-460.
14. Fang LP, Cong P, Feng L, Chen L. Clinical observation on chronic obstructive pulmonary disease in its stable stage treated by principle of invigorating Lung and Kidney. He-nan J Trad Chin Med 2008;27:41-43.
15. Liu X, Fang L, Wei L, et al. Clinical study on influence of Jiajia Zoufei Tang on quality of life in patients with stable chronic obstructive pulmonary disease. New J Trad Chin Med 2005;37:30-31.
16. Wu YQ, Huang ZA. Effect erythromycin combined with Liujunzi Tangn in treatment for stable COPD. Acta Med Si-nica 2007;20:1213-1215.
17. You BW, Zhao SL, Fan FY, Wang SZ. Effect of Yifei Mixture on quality of life of chronic obstructive pulmonary disease patients. Chin J Information Trad Chin Med 2008;15:7-9.
18. Zhang B, Shen Z, Peng S. Strengthening health education and Yi Fei Yin Tang in treatment of chronic obstructive pulmonary disease. Chin J Ethnomed Ethnopharm 2009;18: 159-160.
19. Chen Q, Hong XC, Cai Y, Ye L. Clinical observation of integrated medicine in treating for chronic obstructive pulmonary disease. J Fujian Univ Trad Chin Med 2009;19:12-14.
20. Feng CL, Wu WP, Wan X. Effect of TCM therapy by principle for nourishing Qi, activating blood circulation and resolving phlegm on quality of life of patients with chronic obstructive pulmonary disease. Zhongguo Zhong Xi Yi Jie He Za Zhi 2005;25:829-831.
21. Feng C, Wu W, Wu H, et al. Analysis on clinical materials from 76 cases of COPD treated with qi-replenishing, blood-activating and phlegm-removing therapy. J Beijing Univ Trad Chin Med 2007;30:419.
22. Hong M, Chen W, Cai S, et al. Effect of intervention action of Yufeining on lung function in patients with chronic obstructive pulmonary diseases. China J Trad Chin Med Pharm 2005;20:92-95.
23. Huang D, Wu L, He D, Lin L. Clinical observation of remission stage of chronic obstructive pulmonary disease treated by integration of traditional Chinese medicine and Western medicine. J Fourth Military Med Univ 2005;26:1611-1613.
24. Jia GL, Tong FJ, Yu DZ, Wang HH. Clinical study on Yiqi-huoxue combined ipratropium bromide inhalation in treatment of chronic obstructive pulmonary disease. Zhejiang J Trad Chin Med 2007;42:510-511.
25. Jian X, Huang Z, Lai X, Chen W. Influence of Pingchuan capsule on quality of life of patients with stable chronic obstructive pulmonary disease. J Chin Med Materials 2008; 31:1171-1172.
26. Liang A, Huang M, Gu L, et al. Effect of Dongping Tang with TCM theory 'Winter disease being cured in Summer' on pulmonary function and quality of life in patients with chronic obstructive pulmonary disease in stable stage. Zhe-jiang J Integr Trad Chin West Med 2009;19:333-336.
27. Liu CS. Clinical observation of combination of traditional Chinese medicine and Western medicine on chronic obstructive pulmonary disease with qi deficiency and stasis-phlegn type in stable phase. Hebei J Trad Chin Med 2010; 32:543-547.
28. Liu X, Shan L, Song Y, Zhong L. Effect of blood-activating and phlegm-removing therapy on pulmonary function and quality of life in patients with stable chronic obstructive pulmonary disease. J Guangzhou Univ Trad Chin Med 2006;23:275-278.
29. Mai H. Study of effect on pulmonary function of the patients in stable phase of COPD with invigorating the lung and nourishing the kidney method. J Pract Trad Chin Med 2009; 25:2010-2211.
30. Shan L, Liu X, Zhong L. Influence of integrative medicine on quality of life in patients with stable chronic obstructive pulmonary disease. Liaoning J Trad Chin Med 2007;34:795-796.
31. Sun Z, Liu E, Feng J, Fu M. Therapeutic effect of Bufei Granules for the treatment of chronic obstructive pulmonary disease at stable stage. New J Trad Chin Med 2009;41:37-39.
32. Tang J, Peng L, Yang PL, Huang HY. Clinical observation of combination of traditional Chinese medicine and Western medicine on 30 cases with chronic obstructive pulmonary disease in stable phase. Jiangsu J Trad Chin Med 2010;42:11-12.
33. Zhang M. Clinical study on Jianpi Yifei Bushen in treatment for stable chronic obstructive pulmonary disease. Chin J Inf Trad Chin Med 2006;13:64-65.
34. Zhu L, Pan J, Pan S, Qiu Z. Effect of Tianlong Chuankeling capsule on quality of life for patients with stable chronic obstructive pulmonary disease. J Chin Med Materials 2007; 30:757-759.
35. Feng J. Investigation and discussion of integrative medicine improves on quality of life in patients with stable COPD. J Emergency Trad Chin Med 2008;17:1347-1348.
36. Lang YY, Tang J, Yang PL. Clinical observation on 30 cases of chronic obstructive pulmonary disease in the stable stage with Baibu Yangfei Cream. Henan J Trad Chin Med 2010;30: 867-869.
37. Ni W, Zhang H, Wu D, Li W. Clinical observation of Bushe Naqi recipe combination with routine pharmacotherapy in treatment for chronic obstructive pulmonary. Shanghai J Trad Chin Med 2008;42:15-17.
38. Shi JJ. Treatment based on syndrome differentiation with Western medicine for 90 patients with stable chronic obstructive pulmonary disease. Sanxi J Trad Chin Med 2009; 30:831-832.
39. Tang C, Lin L. Effects of Bailing Capsule on cellular immunity and quality of life of patients with chronic obstructive pulmonary disease in stable stage. Shanghai J Trad Chin Med 2009;43:28-30.
40. Wang C. The influence of Sanshen Jianfei Tang on he-morheology and quality of life of patients with chronic obstructive pulmonary disease. Liaoning J Trad Chin Med 2009;36:1257-1259.
41. Gordon J, Panos RJ. Inhaled albuterol/salbutamol and ipratropium bromide and their combination in the treatment of chronic obstructive pulmonary disease. Expert Opin Drug Metab Toxicol 2010;6:381-392.
42. Du Q, Chen Z, Zhou LF, et al. Inhibitory effects of as-tragaloside IV on ovalbumin-induced chronic experimental asthma. Can J Physiol Pharmacol 2008;86:449-457. (Pubitemid 351948684)
43. Shen HH, Wang K, Li W, et al. Astragalus membranaceus prevents airway hyperreactivity in mice related to Th2 response inhibition. J Ethnopharmacol 2008;116:363-369.
44. Zhang DX, Zhang YK, Nie HJ, et al. Protective effects of new compound codonopsis tablets against acute mountain sickness. Zhongguo Ying Yong Sheng Li Xue Za Zhi 2010; 26:148-152.
45. Li CQ, He LC, Jin JQ. Atractylenolide I and atractylenolide III inhibit lipopolysaccharide-induced TNF-alpha and NO production in macrophages. Phytother Res 2007;21:347-353.
46. Dong H, He L, Huang M, Dong Y. Anti-inflammatory components isolated from Atractylodes macrocephala Koidz. Nat Prod Res 2008;22:1418-1427.
47. Chang HH, Yeh CH, Sheu F. A novel immunomodulatory protein from Poria cocos induces Toll-like receptor 4-depen-dent activation within mouse peritoneal macrophages. J Agric Food Chem 2009;57:6129-6139.
48. Fuchs SM, Heinemann C, Schliemann-Willers S, et al. Assessment of anti-inflammatory activity of Poria cocos in sodium lauryl sulphate-induced irritant contact dermatitis. Skin Res Technol 2006;12:223-227. (Pubitemid 44515668)
49. Lee KY, You HJ, Jeong HG, et al. Polysaccharide isolated from Poria cocos sclerotium induces NF-kappaB/Rel activation and iNOS expression through the activation of p38 ki-nase in murine macrophages. Int Immunopharmacol 2004;4: 1029-1038. (Pubitemid 38844177)
50. Panossian A, Wikman G. Pharmacology of Schisandra chi-nensis Bail.: An overview of Russian research and uses in medicine. J Ethnopharmacol 2008;118:183-212.
51. Guo LY, Hung TM, Bae KH, et al. Anti-inflammatory effects of schisandrin isolated from the fruit of Schisandra chinensis Baill. Eur J Pharmacol 2008;591:293-299.